Objective assessment of psoriasis erythema for PASI scoring
- PMID: 19163606
- DOI: 10.1109/IEMBS.2008.4650103
Objective assessment of psoriasis erythema for PASI scoring
Abstract
Skin colour is vital information in dermatological diagnosis. It reflects pathological condition beneath the skin and commonly being used to indicate the extent of a disease. Psoriasis is a skin disease which is indicated by the appearance of red plaques. Although there is no cure for psoriasis, there are many treatment modalities to help control the disease. To evaluate treatment efficacy, PASI (Psoriasis Area and Severity Index) which is the current gold standard method is used to determine severity of psoriasis lesion. Erythema (redness) is one parameter in PASI. Commonly, the erythema is assessed visually, thus leading to subjective and inconsistent result. In this work, we proposed an objective assessment of psoriasis erythema for PASI scoring. The colour of psoriasis lesion is analyzed by DeltaL, Deltahue, and Deltachroma of CIELAB colour space. References of lesion with different scores are obtained from the selected lesions by two dermatologists. Results based on 38 lesions from 22 patients with various level of skin pigmentation show that PASI erythema score can be determined objectively and consistent with dermatology scoring.
Similar articles
-
Objective assessment of psoriasis erythema for PASI scoring.J Med Eng Technol. 2009;33(7):516-24. doi: 10.1080/07434610902744074. J Med Eng Technol. 2009. PMID: 19639508
-
Area assessment of psoriasis lesion for PASI scoring.Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3446-9. doi: 10.1109/IEMBS.2007.4353072. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18002738
-
Area assessment of psoriasis lesions for PASI scoring.J Med Eng Technol. 2009;33(6):426-36. doi: 10.1080/07434610902744066. J Med Eng Technol. 2009. PMID: 19557605
-
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies.Clin Dermatol. 2010 Jan-Feb;28(1):67-72. doi: 10.1016/j.clindermatol.2009.03.001. Clin Dermatol. 2010. PMID: 20082954 Review.
-
First review on psoriasis severity risk stratification: An engineering perspective.Comput Biol Med. 2015 Aug;63:52-63. doi: 10.1016/j.compbiomed.2015.05.005. Epub 2015 May 14. Comput Biol Med. 2015. PMID: 26005793 Review.
Cited by
-
Improvement effects of a novel Chinese herbal formula in imiquimod and IL-23-stimulated mouse models of psoriasis.Chin Med. 2024 Jun 11;19(1):81. doi: 10.1186/s13020-024-00951-9. Chin Med. 2024. PMID: 38858762 Free PMC article.
MeSH terms
LinkOut - more resources
Medical